Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Invitae Corp. Enters into Definitive Agreement to Acquire ArcherDX

Shares of Invitae Corp. traded 40% higher after the company reported it will acquire ArcherDX in a combination cash and stock deal valued at around $1.4 billion. Advanced medical genetics company Invitae Corp. (NVTA:NYSE) and genomics analysis firm ArcherDX today...

NewLink Genetics Shares Shoot Higher after FDA Ebola Vaccine Approval

Shares of NewLink Genetics got a boost today after the firm reported that the FDA approved its ERVEBO V920 vaccine used in the treatment of Zaire Ebola virus. The company's shares set a new 52-week high price in mid-morning trading. This morning after the U.S. markets...

Seattle Genetics Shares Trade Higher on Q1/20 Earnings and 22% Growth in ADCETRIS Sales

Seattle Genetics shares traded 8% higher, reaching a new 52-week high, after the company reported Q1/20 financial results which included a 10% y-o-y increase in net revenues fueled by a 22% increase in sales of ADCETRIS® and a strong debut for PADCEV™ in its first f...

Fulgent Genetics Hits 52-Week High After Posting 84% Q3 Revenue Increase

Fulgent Genetics shares traded more than 40% higher today after the company reported record revenue in Q3/19. The firm noted that it completed a record 20,697 billable tests in Q3/19, up 272% over the same period last year. After U.S. markets closed yesterday, Temple ...

Myriad Genetics Shares Fall 30% on Q2 Earnings and Executive Leadership Change

Shares of Myriad Genetics traded 30% lower after the firm released Q2/20 earnings and announced the appointment of a new interim CEO. After U.S. markets closed yesterday afternoon, global molecular diagnostics and precision medicine company Myriad Genetics Inc. (M...

Billionaire Eric Sprott Recently Shared His Secrets of Success + his 3 Mining Stock Investments Stri

Billionaire Eric Sprott Recently Shared His Secrets of Success + his 3 Mining Stock Investments Striking the Motherlode amid Coronavirus Scare

Biotech's Topline Breast Cancer Data Impresses

Biotech's Topline Phase 3 HER2-Positive Breast Cancer Data 'Impresses' The results and commercial potential of the therapeutic are discussed in an H.C. Wainwright & Co. report. In an Oct. 22 research note, H.C. Wainwright & Co. analyst Andrew Fein reported that t...

The Vertically-Integrated Cannabis Co. that You Need to Know About

(Click image to play video) Few companies in the North American cannabis space can boast the sheer bounty of product offerings, blue-chip management experience, and extraordinary shareholder value that this established Medford Oregon-based Company can. Halo C...

Billionaire Eric Sprott Recently Shared His Secrets of Success + his 3 Mining Stock Investments Stri

Billionaire Eric Sprott Recently Shared His Secrets of Success + his 3 Mining Stock Investments Striking the Motherlode amid Coronavirus Scare Global Economic Slowdown plus Coronavirus Pandemic Creates Rare, Perfect Setting For Gold and Silver to Thrive Mining...

Arcadia Ropes in $3 Million in GoodHemp Seed Purchase Orders Within 50 Days of Product Launch

Arcadia Biosciences shares traded 25% higher after reporting that it secured $3 million in pre-season GoodHemp seed purchase commitments in just 50 days after launching the product. Arcadia Biosciences Inc. (RKDA:NASDAQ) , which employs science-based approac...
1 2 3 4 5 6 7 8 9 10 ...